Weiss Ratings Issues 'Sell (E+)' Rating for 22nd Century Group (NASDAQ:XXII)

On February 20, 2025, Weiss Ratings reaffirmed its "sell (E+)" rating for 22nd Century Group (NASDAQ:XXII) in a recent update to investors. This rating reflects a cautious outlook on the company's stock performance.

In related news, StockNews.com also adjusted its stance on 22nd Century Group, lowering its rating from "hold" to "sell" in a report published on December 31, 2024.

Stock Performance of 22nd Century Group

On the same day as the Weiss Ratings update, 22nd Century Group's stock opened at $3.35. The company has a debt-to-equity ratio of 1.59, a quick ratio of 0.93, and a current ratio of 1.09. The stock's 50-day simple moving average stands at $5.02, while its 200-day moving average is significantly higher at $23.49. The market capitalization of the company is approximately $5.76 million, with a price-to-earnings (P/E) ratio of 0.00 and a beta of 1.57, indicating a higher volatility compared to the market. Over the past year, the stock has experienced a range, hitting a low of $3.01 and a high of $581.85.

Institutional Investment in 22nd Century Group

Recently, an institutional investor made headlines by acquiring a new stake in 22nd Century Group. Anson Funds Management LP purchased over 3 million shares, representing an investment of about $691,000 during the third quarter of the fiscal year. As per the latest SEC filings, Anson Funds Management LP holds around 6.77% of the company. Collectively, institutional investors own approximately 18.06% of the company’s stock.

Company Overview of 22nd Century Group

22nd Century Group, Inc. specializes in tobacco products, focusing on the sale and distribution of proprietary reduced nicotine tobacco offerings. The company provides low-nicotine content tobacco plants as well as very low nicotine combustible cigarette products. Additionally, it offers contract manufacturing services for conventional tobacco items to various third-party brands. This innovative approach positions the company uniquely within the biotech and tobacco sectors.

Latest News and Insights

• Discover five stocks that analysts prefer over 22nd Century Group.
• Learn how to evaluate dividend stocks effectively.
• Explore how NVIDIA's recent investments are affecting stock prices.
• Gain insights on reading stock charts for beginners.
• Understand the factors driving the recent rally in SoFi stock.
• Identify some of the best large-cap stocks available today.
• Find out about Intel's movements amid M&A discussions.

If you want to stay updated on news and ratings for 22nd Century Group and related companies, consider subscribing to a daily newsletter.

stock, rating, investment